Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ra Medical Systems Inc (RMED)

Ra Medical Systems Inc (RMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter system used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or above- and below-the-knee. Pharos Excimer Laser is a powerful 308 nm ultraviolet-B excimer laser used by physicians as a tool to treat chronic skin diseases, including psoriasis, vitiligo, atopic dermatitis and leukoderma. Ra Medical Systems, Inc. is based in Carlsbad, California.
(Values in U.S. Thousands) Mar, 2023 Dec, 2022 Sep, 2022 Jun, 2022 Mar, 2022
Sales 90 0 0 10 10
Sales Growth unch unch -100.00% unch unch
Net Income -66,400 -8,160 -4,760 -8,450 -5,500
Net Income Growth -713.73% -71.43% +43.67% -53.64% +33.66%
(Values in U.S. Thousands) Mar, 2023 Dec, 2022 Sep, 2022 Jun, 2022 Mar, 2022
Total Assets 48,510 16,840 17,470 14,370 23,750
Total Assets Growth +188.06% -3.61% +21.57% -39.49% +12.88%
Total Liabilities 12,650 7,580 4,960 4,580 5,640
Total Liabilities Growth +66.89% +52.82% +8.30% -18.79% -23.47%
(Values in U.S. Thousands) Mar, 2023 Dec, 2022 Sep, 2022 Jun, 2022 Mar, 2022
Operating Cash Flow -12,050 -22,570 -19,540 -14,580 -8,570
Operating Cash Flow Growth +46.61% -15.51% -34.02% -70.13% +68.98%
Net Cash Flow -3,640 810 -1,390 -3,920 2,610
Change in Net Cash Flow -549.38% +158.27% +64.54% -250.19% +129.46%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar